Arkolith/Insider Trading/CGTX/Form 4

Doyle John Brendan

Chief Financial OfficerCOGNITION THERAPEUTICS INC (CGTX) · full profile →Form 4 · filed Feb 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Tax withholding(F)27K$1.03$28K619K
Feb 3, 2026Grant(A)200K—$0646K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-011074) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML